Protein expression
Gene:
MAGEA10 (official gene symbol)Other symbol:
MAGEA10CT family:
CT1CT identifier:
CT1.10Aliases from NCBI:
MAGE10 , MGC10599Published data of protein expression in neoplasias
Bladder cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Infiltrating urothelial carcinoma |
21/67 (31%) | IHC | 21080435 | |
| Infiltrating urothelial carcinoma |
21/67 (31%) | Tissue microarray (IHC) | 21710496 | |
| Noninvasive urothelial carcinoma |
7/36 (19%) | Tissue microarray (IHC) | ||
| Non-muscle-invasie bladder carcinoma |
26/79 (33%) | IHC | 23125074 |
Breast cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Medullary cancer |
5/49 (10%) | Tissue microarray (IHC) | 21710496 | |
| Breast carcinoma |
ER/PR/HER2 triple-negative tumors | 104/164 (63%) | IHC | 22116775 |
| Breast carcinoma |
55/75 (73%) | IHC | 22198676 |
Colon & Rectum cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Colorectal carcinoma |
0/14 (0%) | IHC | 16960690 |
Esophageal cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Adenocarcinoma |
1/8 (12.5%) | IHC | 15355897 | |
| Adenocarcinoma |
Primary tumor | 10/59 (16.9%) | IHC | |
| BM |
0/9 (0%) | IHC | ||
| Dysplasia |
0/11 (0%) | IHC | ||
| Squamous cell carcinoma |
8/31 (26%) | Tissue microarray (IHC) | 21710496 |
Gastric cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Adenocarcinoma, intestinal type |
11/49 (22%) | Tissue microarray (IHC) | 21710496 |
Gynecological cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Endometrioid adenocarcinoma |
5/49 (10%) | Tissue microarray (IHC) | 21710496 | |
| Serous adenocarcinoma (endometrium) |
10/32 (31%) | Tissue microarray (IHC) |
Head & Neck cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Squamous cell carcinoma of the larynx |
5/24 (21%) | Tissue microarray (IHC) | 21710496 |
Hepatobiliary cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Gall bladder adenocarcinoma |
5/34 (15%) | Tissue microarray (IHC) | 21710496 |
Lung cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Squamous cell carcinoma |
15/43 (35%) | IHC | 21080435 | |
| Adenocarcinoma |
9/75 (12%) | Tissue microarray (IHC) | 21710496 | |
| Large cell carcinoma |
3/20 (15%) | Tissue microarray (IHC) | ||
| Small cell carcinoma |
6/44 (13%) | Tissue microarray (IHC) | ||
| Squamous cell carcinoma |
15/43 (35%) | Tissue microarray (IHC) |
Melanocytic lesion Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Melanoma |
19/50 (38%) | IHC | 21080435 | |
| Melanoma |
19/50 (38%) | Tissue microarray (IHC) | 21710496 |
OTHER CANCER Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Mesothelioma of the pleura |
5/28 (18%) | Tissue microarray (IHC) | 21710496 |
Ovarian cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Serous ovarian adenocarcinoma |
8/40 (20%) | Tissue microarray (IHC) | 21710496 |
Skin cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Basalioma |
19/59 (32%) | IHC | 21080435 | |
| Basalioma |
19/59 (32%) | Tissue microarray (IHC) | 21710496 |
Testicular cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Seminoma |
15/47 (32%) | Tissue microarray (IHC) | 21710496 |
Available antibodies
polyclonal antibody Rimoldi et al., 1999 PMID: 10446460
monoclonal antibody GA11.1 Schultz-Thater et al., 2011 PMID:21710496